All sponsors

Ascendis Pharma A/S $ASND

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS2
Open Ascendis Pharma A/S on the live radar map → 📅 $ASND readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Palopegteriparatide
NCT07706764
P3RecruitingHypoparathyroidism122027-08
teACH
NCT06732895
P2Active, not recruitingAchondroplasia252027-09 (+9 mo)
Navepegritide
NCT06079398
P2RecruitingAchondroplasia722027-12 (+21 mo)
Lonapegsomatropin [SKYTROFA®]
NCT07221851
P3RecruitingTurner Syndrome; Short Stature Homeobox Gene Mutation1862028-02
cAtCH
NCT07924059
P3Not yet recruitingAchondroplasia1442028-09
HCH UpliftMono
NCT07917143
P3Not yet recruitingHypochondroplasia812028-10